Posts filed under: HC21 News

Now that the UK is getting back on track after Covid-19, attention is very much on clearing a huge backlog of postponed surgeries and operations. Whilst this is true for most therapy areas, some have been impacted more severely than...
Continue Reading →
Neovasc’s Reducer System has been included on the NHS High-Cost Tariff Excluded Devices (HCTED) programme, which aims to provide value for money for both hospitals and medical device suppliers. Equipment developed and manufactured by Canadian biotech firm Neovasc for treating Refractory Angina...
Continue Reading →
Our partners at Hologic invite you to attend a live educational webinar on MyoSure® Hyesteroscopic Tissue Removal. As more operative procedures are moved into the outpatient clinic, Hologic are exploring different practices and experiences of using MyoSure in this setting,...
Continue Reading →
At Healthcare 21 we are steadfast in our commitment to supporting ongoing education and innovation in our industry. Our Primary Care and Mobility Team’s knowledge and expertise confirm our role as market leaders in the Irish mobility market.  Healthcare 21...
Continue Reading →